Diabetes mellitus and prostate cancer risk: A mendelian randomization analysis

World J Diabetes. 2023 Dec 15;14(12):1839-1848. doi: 10.4239/wjd.v14.i12.1839.

Abstract

Background: Some studies have directed towards an association between diabetes mellitus (DM) and prostate cancer (PCa); however, this specific relationship remains inconclusive. In recent years, Mendelian randomization (MR) has become a widely used analytical method for inferring epidemiological causes.

Aim: To investigated the potential relationship between DM and PCa using MR.

Methods: We downloaded relevant data on "diabetes" and "PCa" from the IEU OpenGWAS project database, performed three different methods to conduct MR, and carried out sensitivity analysis for verification.

Results: The results indicated that DM was an independent risk factor for PCa. The odds ratio (OR) values obtained using the inverse variance weighted method in this study were as follows: OR = 1.018 (95% confidence interval: 1.004-1.032), P = 0.014.

Conclusion: We found that DM could increase the incidence rate of PCa.

Keywords: Diabetes mellitus; Genome-wide association study; Mendelian randomization analysis; Prostate cancer; Risk factors.